WHO ICTRP trial
PER-006-02 · MERCK SHARP & DOHME PERU S.R.L.,
PER-006-02 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-006-02 |
|---|---|
| Scientific title | A THREE-MONTH DOUBLE-BLIND, MULTICENTRE, CONTROLLED STUDY COMPARING 2% DORZOLAMIDE, EYE DROPS, SOLUTION, AND OF 0.5% TIMOLOL,IN PAEDIATRIC PATIENTS OF LESS THAN 6 YEARS OF AGE WITH ELEVATED INTRAOCULAR PRESSURE OR GLAUCOMA |
| Primary sponsor | MERCK SHARP & DOHME PERU S.R.L., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | IV |
| Countries | Peru |
| Conditions | -H409 Glaucoma, unspecified Glaucoma, unspecified;H409;Glaucoma, unspecified |
| Interventions | Group name:dorzolamide Type of group;1 N° of participants:100 Intervention(s) description:Dorzolamide 2% three times daily in the eye (s) of the study, in the morning. Group name:timolol SG Type of group;2 N° of participants:50… |
| Registration date | Oct 1, 2002 |
| Target size | 6 |
| Secondary IDs | NO DISPONIBLE;NO DISPONIBLE;NO DISPONIBLE |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: